Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jad.2021.09.012 | DOI Listing |
Publication Analysis
Top Keywords
corrigendum "lurasidone
4
"lurasidone long-term
4
long-term treatment
4
treatment bipolar
4
bipolar depression
4
depression 28-week
4
28-week open
4
open label
4
label extension
4
extension study"
4
Similar Publications
[This corrects the article DOI: 10.1016/j.heliyon.
View Article and Find Full Text PDFCorrigendum: Cost-utility analysis of lurasidone for the first-line treatment of schizophrenia in China.
Front Public Health
November 2022
School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
[This corrects the article DOI: 10.3389/fpubh.2022.
View Article and Find Full Text PDFCorrigendum to "Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study". [Journal of Affective Disorders 281 (2021) 160-167].
J Affect Disord
January 2022
Japan Depression Center, Tokyo, Japan; National Center of Neurology and Psychiatry, Japan.
Corrigendum to "Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study". [Journal of Affective Disorders 281 (2021) 160-167].
J Affect Disord
September 2021
Japan Depression Center, Tokyo, Japan; National Center of Neurology and Psychiatry, Japan.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!